Top

Published in:

01-05-2020 | Leflunomide | News item

Teriflunomide linked with new onset and worsening of psoriasis

Published in: Reactions Weekly | Issue 1/2020

Excerpt

Teriflunomide (Aubagio) is potentially associated with new onset of psoriasis ¹ and worsening of pre-existing psoriasis, says Ireland's Health Products Regulatory Authority (HPRA). …

including pustular psoriasis

indicated for the treatment of active rheumatoid arthritis and active psoriatic arthritis.

including the Summary of Product Characteristics and Package Leaflet.

Health Products Regulatory Authority. Aubagio (teriflunomide) - Risk of new onset of psoriasis and worsening of pre-existing psoriasis. Internet Document : [1 page], 13 May 2020. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/

Title: Teriflunomide linked with new onset and worsening of psoriasis
Publication date: 01-05-2020
Publisher: Springer International Publishing
Keywords: Leflunomide
Pustular Psoriasis
Vulgar Psoriasis
Teriflunomide
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-78711-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Teriflunomide linked with new onset and worsening of psoriasis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Ipilimumab/nivolumab/pembrolizumab

Antineoplastics/immunosuppressants

Prednisone

Pioglitazone

Scopolamine butylbromide

Levetiracetam/pantoprazole